Royalty Pharma plc Class A Ordinary Shares (RPRX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for RPRX. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 254 institutions reported holding RPRX, with 239.6 million shares worth $14.0 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Morgan Stanley | 41,101,267 | $2.4B | DECREASED |
| Capital Group | 34,025,436 | $2.0B | DECREASED |
| BlackRock | 29,117,396 | $1.7B | INCREASED |
| FMR | 19,348,880 | $1.1B | DECREASED |
| State Street | 12,951,600 | $756M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Marshall Urist (EVP, Research & Investments) | OTHER | 150,000 | 2026-11-06 | |
| Marshall Urist (EVP, Research & Investments) | OTHER | 150,000 | 2026-11-06 | |
| Terrance P. Coyne (EVP & CFO) | OTHER | 100,000 | 2026-11-06 | |
| Terrance P. Coyne (EVP & CFO) | OTHER | 150,000 | 2026-11-06 | |
| Terrance P. Coyne (EVP & CFO) | OTHER | 100,000 | 2026-11-06 |
Full institutional holdings, insider history, and congressional trades for Royalty Pharma plc Class A Ordinary Shares on SentiSense.